Concepts (263)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 12 | 2025 | 543 | 3.510 |
Why?
|
| Polyglycolic Acid | 7 | 2017 | 18 | 2.480 |
Why?
|
| Lactic Acid | 6 | 2017 | 75 | 2.290 |
Why?
|
| Glioblastoma | 6 | 2022 | 159 | 2.170 |
Why?
|
| Brain Neoplasms | 7 | 2023 | 317 | 1.830 |
Why?
|
| Drug Delivery Systems | 8 | 2025 | 333 | 1.690 |
Why?
|
| Central Nervous System | 4 | 2025 | 200 | 1.440 |
Why?
|
| Brain | 9 | 2025 | 1598 | 1.280 |
Why?
|
| Blood-Brain Barrier | 6 | 2025 | 87 | 1.190 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2024 | 37 | 1.100 |
Why?
|
| Cerebrospinal Fluid | 2 | 2025 | 29 | 1.060 |
Why?
|
| Tissue Scaffolds | 4 | 2017 | 90 | 1.030 |
Why?
|
| Polyethylene Glycols | 4 | 2025 | 171 | 0.950 |
Why?
|
| Cisterna Magna | 1 | 2025 | 17 | 0.940 |
Why?
|
| Hydrogels | 4 | 2016 | 124 | 0.930 |
Why?
|
| Camptothecin | 2 | 2015 | 29 | 0.910 |
Why?
|
| Drug Carriers | 4 | 2017 | 187 | 0.880 |
Why?
|
| Methotrexate | 1 | 2025 | 80 | 0.880 |
Why?
|
| Polystyrenes | 2 | 2025 | 35 | 0.840 |
Why?
|
| Cerebellar Neoplasms | 1 | 2023 | 10 | 0.820 |
Why?
|
| Medulloblastoma | 1 | 2023 | 13 | 0.820 |
Why?
|
| Hydroxamic Acids | 3 | 2024 | 28 | 0.810 |
Why?
|
| Positron-Emission Tomography | 3 | 2014 | 228 | 0.790 |
Why?
|
| Animals | 30 | 2025 | 21295 | 0.780 |
Why?
|
| Tissue Distribution | 7 | 2025 | 292 | 0.770 |
Why?
|
| Estradiol | 4 | 2017 | 260 | 0.710 |
Why?
|
| beta-Cyclodextrins | 1 | 2021 | 21 | 0.690 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 174 | 0.660 |
Why?
|
| Cell Proliferation | 3 | 2017 | 1029 | 0.640 |
Why?
|
| Cell Line, Tumor | 9 | 2022 | 1558 | 0.640 |
Why?
|
| Acrylic Resins | 2 | 2017 | 20 | 0.630 |
Why?
|
| Neoplastic Stem Cells | 2 | 2022 | 196 | 0.620 |
Why?
|
| Paclitaxel | 2 | 2009 | 102 | 0.570 |
Why?
|
| Spinal Cord | 1 | 2019 | 208 | 0.560 |
Why?
|
| Injections, Spinal | 3 | 2025 | 45 | 0.540 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 33 | 0.540 |
Why?
|
| Mice | 14 | 2025 | 11083 | 0.540 |
Why?
|
| Cell Culture Techniques | 2 | 2017 | 195 | 0.540 |
Why?
|
| Organ Specificity | 1 | 2018 | 197 | 0.520 |
Why?
|
| Hormone Replacement Therapy | 1 | 2017 | 30 | 0.520 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2017 | 29 | 0.500 |
Why?
|
| Tissue Engineering | 2 | 2015 | 147 | 0.500 |
Why?
|
| Fluorine Radioisotopes | 1 | 2014 | 8 | 0.450 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2013 | 138 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 3459 | 0.430 |
Why?
|
| Menopause | 1 | 2017 | 256 | 0.430 |
Why?
|
| Temperature | 1 | 2015 | 311 | 0.420 |
Why?
|
| Glioma | 1 | 2015 | 99 | 0.410 |
Why?
|
| Leydig Cell Tumor | 1 | 2013 | 3 | 0.410 |
Why?
|
| Vitamin E | 1 | 2013 | 55 | 0.400 |
Why?
|
| Testicular Neoplasms | 1 | 2013 | 35 | 0.400 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2015 | 44 | 0.390 |
Why?
|
| Radiopharmaceuticals | 1 | 2013 | 190 | 0.380 |
Why?
|
| Adrenal Glands | 2 | 2003 | 34 | 0.370 |
Why?
|
| Polyesters | 2 | 2023 | 44 | 0.370 |
Why?
|
| src-Family Kinases | 2 | 2003 | 64 | 0.360 |
Why?
|
| Subarachnoid Space | 2 | 2023 | 15 | 0.360 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 3 | 2021 | 278 | 0.330 |
Why?
|
| Styrenes | 1 | 2009 | 3 | 0.320 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2010 | 34 | 0.310 |
Why?
|
| Rats | 7 | 2021 | 1997 | 0.310 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2009 | 45 | 0.300 |
Why?
|
| Apoptosis | 2 | 2017 | 1091 | 0.300 |
Why?
|
| Drug-Eluting Stents | 1 | 2009 | 68 | 0.290 |
Why?
|
| Antineoplastic Agents | 3 | 2021 | 641 | 0.290 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 228 | 0.280 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2014 | 624 | 0.280 |
Why?
|
| Arteries | 1 | 2008 | 81 | 0.270 |
Why?
|
| Hippocampus | 1 | 2010 | 274 | 0.270 |
Why?
|
| Infusions, Intraventricular | 2 | 2025 | 12 | 0.270 |
Why?
|
| Humans | 18 | 2024 | 64795 | 0.270 |
Why?
|
| Cell Survival | 4 | 2017 | 580 | 0.260 |
Why?
|
| Injections, Intraventricular | 2 | 2025 | 23 | 0.260 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 202 | 0.260 |
Why?
|
| Biological Transport | 2 | 2020 | 292 | 0.240 |
Why?
|
| Chemokine CXCL12 | 2 | 2016 | 27 | 0.240 |
Why?
|
| Laminin | 2 | 2016 | 81 | 0.240 |
Why?
|
| Tumor Cells, Cultured | 2 | 2017 | 426 | 0.230 |
Why?
|
| Hyaluronic Acid | 2 | 2016 | 70 | 0.230 |
Why?
|
| Male | 11 | 2025 | 30811 | 0.230 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2025 | 61 | 0.220 |
Why?
|
| Sheep | 1 | 2025 | 189 | 0.220 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 870 | 0.220 |
Why?
|
| Models, Biological | 1 | 2009 | 1204 | 0.210 |
Why?
|
| Caproates | 1 | 2023 | 1 | 0.210 |
Why?
|
| Lactones | 1 | 2023 | 16 | 0.200 |
Why?
|
| Indoles | 1 | 2024 | 111 | 0.200 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2023 | 38 | 0.200 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2003 | 13 | 0.200 |
Why?
|
| Depression | 1 | 2010 | 890 | 0.190 |
Why?
|
| Particle Size | 2 | 2015 | 428 | 0.190 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2013 | 80 | 0.190 |
Why?
|
| Macaca mulatta | 1 | 2023 | 260 | 0.190 |
Why?
|
| Biocompatible Materials | 2 | 2015 | 152 | 0.180 |
Why?
|
| Aldosterone | 1 | 2001 | 18 | 0.170 |
Why?
|
| Diffusion | 2 | 2013 | 82 | 0.170 |
Why?
|
| Amines | 1 | 2021 | 31 | 0.170 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2021 | 89 | 0.170 |
Why?
|
| Delayed-Action Preparations | 1 | 2021 | 119 | 0.160 |
Why?
|
| Cerebral Ventricles | 1 | 2020 | 29 | 0.160 |
Why?
|
| Micelles | 1 | 2020 | 83 | 0.150 |
Why?
|
| Liposomes | 1 | 2020 | 116 | 0.150 |
Why?
|
| Receptors, CXCR4 | 2 | 2016 | 43 | 0.150 |
Why?
|
| Infratentorial Neoplasms | 1 | 2018 | 4 | 0.150 |
Why?
|
| Ependymoma | 1 | 2018 | 5 | 0.150 |
Why?
|
| Azacitidine | 1 | 2018 | 15 | 0.150 |
Why?
|
| Child | 3 | 2023 | 4603 | 0.150 |
Why?
|
| Elasticity | 2 | 2015 | 45 | 0.140 |
Why?
|
| Viscosity | 2 | 2015 | 59 | 0.140 |
Why?
|
| Neural Stem Cells | 2 | 2016 | 48 | 0.140 |
Why?
|
| Time Factors | 3 | 2015 | 3744 | 0.140 |
Why?
|
| Sonication | 1 | 2018 | 15 | 0.140 |
Why?
|
| Levonorgestrel | 1 | 2017 | 10 | 0.140 |
Why?
|
| Nootropic Agents | 1 | 2017 | 13 | 0.140 |
Why?
|
| Ovariectomy | 1 | 2017 | 103 | 0.130 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 13 | 0.130 |
Why?
|
| Memory, Short-Term | 1 | 2017 | 63 | 0.130 |
Why?
|
| Optical Phenomena | 1 | 2017 | 8 | 0.130 |
Why?
|
| Gene Products, tat | 1 | 2017 | 14 | 0.130 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 464 | 0.120 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2021 | 511 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 156 | 0.120 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 80 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2018 | 201 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 2 | 2017 | 235 | 0.120 |
Why?
|
| Centrifugation | 1 | 2015 | 10 | 0.120 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2015 | 35 | 0.120 |
Why?
|
| Acrylamides | 1 | 2015 | 13 | 0.120 |
Why?
|
| Chromatography, Gel | 1 | 2015 | 63 | 0.110 |
Why?
|
| Rheology | 1 | 2015 | 83 | 0.110 |
Why?
|
| Avidin | 1 | 2014 | 12 | 0.110 |
Why?
|
| Half-Life | 1 | 2014 | 81 | 0.110 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 159 | 0.110 |
Why?
|
| Isotope Labeling | 1 | 2014 | 68 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2017 | 620 | 0.110 |
Why?
|
| Biotin | 1 | 2014 | 54 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2016 | 141 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 430 | 0.110 |
Why?
|
| DNA Primers | 3 | 2010 | 300 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 277 | 0.110 |
Why?
|
| Ligands | 1 | 2015 | 416 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2015 | 189 | 0.110 |
Why?
|
| Gene Expression | 2 | 2016 | 856 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 285 | 0.100 |
Why?
|
| Sepharose | 1 | 2013 | 7 | 0.100 |
Why?
|
| Cognition | 1 | 2017 | 501 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2013 | 108 | 0.100 |
Why?
|
| Cell Nucleus Shape | 1 | 2013 | 5 | 0.100 |
Why?
|
| Neostriatum | 1 | 2013 | 26 | 0.100 |
Why?
|
| Cyclopentanes | 1 | 2013 | 9 | 0.100 |
Why?
|
| Dithiazanine | 1 | 2013 | 1 | 0.100 |
Why?
|
| Viral Proteins | 1 | 2015 | 270 | 0.100 |
Why?
|
| Heart | 1 | 2015 | 295 | 0.100 |
Why?
|
| Peptide Fragments | 1 | 2015 | 416 | 0.100 |
Why?
|
| Molecular Weight | 1 | 2013 | 193 | 0.100 |
Why?
|
| Quinolines | 1 | 2013 | 46 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 39 | 0.100 |
Why?
|
| Mice, Nude | 1 | 2013 | 287 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 348 | 0.100 |
Why?
|
| Base Sequence | 3 | 2010 | 1327 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2015 | 579 | 0.090 |
Why?
|
| Survival Rate | 1 | 2015 | 847 | 0.090 |
Why?
|
| Testis | 1 | 2013 | 161 | 0.090 |
Why?
|
| Female | 6 | 2024 | 33770 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2010 | 610 | 0.090 |
Why?
|
| Aging | 1 | 2017 | 763 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1382 | 0.090 |
Why?
|
| DNA Damage | 1 | 2013 | 293 | 0.090 |
Why?
|
| Cyclin B1 | 1 | 2010 | 9 | 0.080 |
Why?
|
| Spermatids | 1 | 2010 | 11 | 0.080 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2010 | 48 | 0.080 |
Why?
|
| Estrogen Receptor beta | 1 | 2010 | 24 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2010 | 49 | 0.080 |
Why?
|
| Emulsions | 1 | 2013 | 493 | 0.080 |
Why?
|
| Receptor, trkA | 1 | 2010 | 3 | 0.080 |
Why?
|
| Glucuronic Acid | 1 | 2010 | 20 | 0.080 |
Why?
|
| Hexuronic Acids | 1 | 2010 | 23 | 0.080 |
Why?
|
| Osmosis | 1 | 2009 | 6 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 46 | 0.080 |
Why?
|
| Polyvinyls | 1 | 2010 | 19 | 0.080 |
Why?
|
| Microscopy, Atomic Force | 1 | 2009 | 31 | 0.080 |
Why?
|
| Microspheres | 1 | 2010 | 56 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2024 | 1285 | 0.080 |
Why?
|
| Alginates | 1 | 2010 | 50 | 0.080 |
Why?
|
| Solubility | 1 | 2009 | 192 | 0.080 |
Why?
|
| Coronary Stenosis | 1 | 2009 | 41 | 0.070 |
Why?
|
| Elastin | 1 | 2008 | 11 | 0.070 |
Why?
|
| Glass | 1 | 2008 | 23 | 0.070 |
Why?
|
| Neuronal Plasticity | 1 | 2010 | 152 | 0.070 |
Why?
|
| Cell Line | 2 | 2003 | 2036 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2010 | 236 | 0.070 |
Why?
|
| Aorta | 1 | 2008 | 109 | 0.070 |
Why?
|
| Exons | 1 | 2008 | 207 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 177 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 146 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 543 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 403 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2008 | 310 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 850 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2003 | 1573 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2010 | 472 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 1690 | 0.050 |
Why?
|
| Drug Stability | 1 | 2024 | 144 | 0.050 |
Why?
|
| Species Specificity | 1 | 2024 | 341 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2003 | 27 | 0.050 |
Why?
|
| Kinetics | 1 | 2024 | 758 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2023 | 138 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2003 | 223 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2023 | 286 | 0.040 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2001 | 1 | 0.040 |
Why?
|
| Chromatography, Thin Layer | 1 | 2001 | 16 | 0.040 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 1 | 2001 | 9 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 2001 | 152 | 0.040 |
Why?
|
| Fourth Ventricle | 1 | 2018 | 3 | 0.040 |
Why?
|
| Spatial Memory | 1 | 2017 | 8 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2017 | 56 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1274 | 0.030 |
Why?
|
| Maze Learning | 1 | 2017 | 51 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 2017 | 63 | 0.030 |
Why?
|
| Neurofibromin 1 | 1 | 2017 | 14 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 1211 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 364 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 2016 | 30 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2018 | 302 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 461 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 764 | 0.030 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2016 | 42 | 0.030 |
Why?
|
| Gelatin | 1 | 2015 | 29 | 0.030 |
Why?
|
| Solutions | 1 | 2015 | 64 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 158 | 0.030 |
Why?
|
| Serum Albumin, Bovine | 1 | 2015 | 35 | 0.030 |
Why?
|
| Methacrylates | 1 | 2015 | 40 | 0.030 |
Why?
|
| Injections | 1 | 2015 | 83 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2015 | 140 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2015 | 50 | 0.030 |
Why?
|
| Cell Count | 1 | 2015 | 131 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 241 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 214 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 121 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2015 | 140 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 1002 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 198 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 318 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2017 | 961 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 476 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 373 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2270 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2015 | 415 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2017 | 632 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 297 | 0.030 |
Why?
|
| Fluorescence | 1 | 2013 | 93 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2018 | 2052 | 0.020 |
Why?
|
| Swine | 1 | 2013 | 395 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 417 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 2190 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 236 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1466 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 129 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2010 | 211 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 389 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1635 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 5757 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 3147 | 0.020 |
Why?
|